Reshaping Brain Health with Precision Neuropsychiatry
Unveil Comprehensive Insights into Brain Healthcare
Empowering Neuropsychiatry with Precise, Objective Measures
At Sama Therapeutics, we meld artificial intelligence, neurotechnology, and exhaustive scientific inquiry to engineer tools that furnish objective, quantifiable assessments of brain activity. Transmuting these measurements into actionable insights, we are advancing the management of mental health and neurological disorders towards a more data-driven paradigm.
Redefining Neuropsychiatry through Cloud Analytics
Our cloud analytics infrastructure revolutionizes the assessment and management of mental health and neurological disorders. By delivering potent insights into patient data, we equip clinicians with a deeper comprehension of their patients' conditions, fostering more informed care decisions.
Tailored Solutions for Precision Neuropsychiatry
Our arsenal of tools is engineered for versatility and customization, facilitating a tailored approach to each patient's unique needs. We champion precision psychiatry as the linchpin for elevating mental health care, and our solutions are sculpted to manifest this belief.
Fueling Neuropsychiatry's Evolution with Data Science
Data science is our cornerstone. Employing cutting-edge data science methodologies, we dissect patient data to unearth insights into mental health and neurological disorders. Our devoted data science ensemble is at the vanguard of propelling precision psychiatry to new frontiers.
Holistic Patient-Centric Care
We pledge an unwavering commitment to superior patient care. Our holistic patient experience service ensures personalized attention and tailored treatment pathways, nurturing a supportive journey towards improved mental health.
Advancing Precision Neuropsychiatry with Cutting-Edge Technology
Award-Winning Predictive Algorithm
Engaged in a challenge to unearth clinically actionable biomarkers, with a focus on ADHD and MDD. A unique 30% of data tagged as replication was set for blind validation. Our predictive acumen shone as we topped the table, marking a stride towards innovative psychiatric and neurological care.
At Sama, we are pioneering advancements in the realm of neuroscientific solutions. Our multifaceted approach encompasses a dynamic research platform for streamlined data processing, an FDA-approved integration to standard EEG systems, and bespoke data analysis services tailored for researchers and the pharmaceutical industry. As a trailblazer in the cognitive health sector, our offerings cater to diverse needs while upholding the highest standards of precision and reliability.
Precision Psychiatry Platform
Introducing our state-of-the-art Research Platform: Designed for the modern neuroscientist, our platform revolutionizes the way EEG, ECG, and other neurodata are processed. Equipped with cutting-edge algorithms and an intuitive user interface, it facilitates efficient data analysis and provides actionable insights. Whether you're delving into in-depth research studies or are in the preliminary stages of data exploration, our platform streamlines operations, ensuring that your focus remains on drawing meaningful conclusions and advancing the field of neurology.
Clinical Routine EEG plugin
Unlock the potential of clinical EEG assessments with our innovative, FDA-approved (pending) EEG Headset Plugin. Specially crafted for the demanding clinical environment, this advanced tool seamlessly integrates with existing EEG systems. It offers an unparalleled advantage by comparing patient data in real-time to a comprehensive normative database. With enhanced diagnostic precision and accelerated interpretation capabilities, our plugin transforms routine EEGs into a powerful instrument for clinical decision-making, setting a new standard in patient care.
Navigating the vast ocean of neurophysiological data can be overwhelming. With our specialized NeuroData Analysis Services, we stand at the forefront of decoding complex EEG, ECG, and other neurological data sets. Specifically tailored for pharmaceutical companies and dedicated researchers, our service transforms raw data into actionable insights. We empower your research with precision, ensuring that every piece of data is meticulously analyzed to unlock its full potential. With our expertise, you can accelerate your research, gain deeper insights, and elevate your studies to unparalleled heights.
Meet the Team
At Sama Therapeutics, our team is our cornerstone. Comprising seasoned professionals from the realms of psychiatry, neurotechnology, data science, and healthcare innovation, we are united by a shared vision – to redefine the landscape of mental health care through precision psychiatry. Each member brings a wealth of expertise and a relentless drive for innovation, contributing to the collective endeavor of creating impactful, data-driven solutions for mental health and neurological disorders. Together, we are advancing the frontier of psychiatric care, committed to making a tangible difference in the lives of individuals and communities we serve.
Shobi Ahmed, MD, PhD
Chief Executive Officer
Tyler Moore, PhD
Chief Development Advisor
Aurina Arnatkeviciute, PhD
Principal Data Scientist
Kristel Carrington, MD
Chief Medical Officer
Alan Tucholka, PhD
Chief Technology Officer
Russel Hanson, PhD
Chief Innovation Officer
Adam Teed, PhD
Chief Operating Officer
Elias Mouchlianitis, PhD
Chief Scientific Officer
Karim El Kanbi, PhD
Principal Machine Learning Engineer
Our Scientific Advisory Board
The Scientific Advisory Board at Sama Therapeutics is a congregation of eminent minds from the realms of psychiatry, neurotechnology, data science, and healthcare innovation. Their collective wisdom, honed at the pinnacle of academic and professional excellence, navigates our venture through the complex landscape of precision psychiatry. With an eye on the horizon of psychiatric and neurological advancements, they ensure our pursuits are rooted in scientific rigor, ethical integrity, and a relentless aspiration for bettering mental healthcare. Their counsel empowers our mission to unveil objective, quantifiable insights into mental health, propelling us closer to our vision of redefining mental healthcare through data-driven innovation.
Diego Pizzagalli, PhD
Professor, Psychiatry Harvard Medical School
Stephen Morse, JD, PhD
Professor of Law in Psychiatry, University of Pennsylvania
Laura Bevilacqua, MD, PhD
Psychiatrist & Professor, Mt Sinai School of Medicine
Martijn Arns, PhD
Professor, Neuroscience, Maastricht University, Director, Brainclinics
Konrad Kording, PhD
John Allen, PhD
Professor, PIK, University of Pennsylvania
Distinguished Professor, Psychology, University of Arizona
Adam Safron, PhD
Rex Jung, PhD
Founding Chief Scientific Officer, Postdoc, JHU
Professor of Neurosurgery, University of New Mexico
We are not just at the forefront of precision psychiatry; we are avid contributors to the global scientific dialogue. Our team of seasoned professionals and emerging scholars regularly publish in reputable peer-reviewed journals, sharing our findings, methodologies, and innovations with the wider scientific and medical communities. Our publications span a myriad of topics within psychiatry, neurotechnology, and data science, reflecting the breadth and depth of our expertise. Through rigorous research and a commitment to open dissemination of knowledge, we aim to foster a collaborative ecosystem, drive the field forward, and uphold our ethos of transparency and academic integrity. Explore our diverse range of publications and delve into the cutting-edge research that underpins our mission to revolutionize mental healthcare.
Tyler M Moore [...], Raquel E Gur, Ruben C Gur. Construction of a computerized adaptive test (CAT-CCNB) for efficient neurocognitive and clinical psychopathology assessment. J Neurosci Methods. 2023.
Adam R. Teed, Justin S. Feinstein, [...], Wesley K. Thompson, Martin P. Paulus, Sahib S. Khalsa. Association of Generalized Anxiety Disorder With Autonomic Hypersensitivity and Blunted Ventromedial Prefrontal Cortex Activity During Peripheral Adrenergic Stimulation.
A Randomized Clinical Trial. JAMA Psychiatry. 2022.
Adam Safron. Integrated world modeling theory expanded: Implications for the future of consciousness. Front. Comput. Neurosci. 2022
Elias Mouchlianitis [...], James Stone, Oliver D. Howes. Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive. Schizophrenia Bulletin. 2016.
Adam Safron, Zahra Sheikhbahaee. Towards Understanding Persons and Their Personalities with Cybernetic Big 5 Theory and the Free Energy Principle and Active Inference (FEP-AI) Framework. PsyArXiv, 26 June 2023.
Tyler M Moore, Steven P Reise [...], Ruben C Gur. Psychometric properties of the Penn Computerized Neurocognitive Battery. Neuropsychology. 2015.
Alan Tucholka, Virgile Fritsch, Jean-Baptiste Poline, Bertrand Thirion. An empirical comparison of surface-based and volume-based group studies in neuroimaging. NeuroImage. 2012.
Aurina Arnatkeviciute, Ross D. Markello, Ben D. Fulcher, Bratislav Misic, Alex Fornito. Toward Best Practices for Imaging Transcriptomics of the Human Brain, Biological Psychiatry. 2023.
At Sama Therapeutics, geographical boundaries do not confine our quest for excellence. We handpick the crème de la crème from every corner of the globe, uniting a cadre of experts unparalleled in their respective fields. Our strategy is simple yet effective – the right person for the right job, regardless of where they call home. This global tapestry of talent not only enriches our collective expertise but ensures there's always a Sama representative at work, no matter the time zone. Our dispersed yet cohesive team embodies a blend of diverse perspectives and unique skills, driving innovation in precision psychiatry around the clock. As we traverse time zones and cross cultural chasms, our shared mission of redefining mental healthcare through data-driven innovation remains the steadfast compass guiding our collaborative endeavors.